Scholarlink

Purpose <p>This multicentric, retrospective study aimed to analyze the safety and effectiveness of the mAXIS Stapes Prosthesis, mLOOP Stapes Prosthesis, mZAM Stapes Prosthesis, and mFIX Stapes Prosthesis.</p> Methods <p>Patients underwent stapes surgery and implantation of a mAXIS Stapes Prosthesis, mLOOP Stapes Prosthesis, mZAM Stapes Prosthesis, or mFIX Stapes Prosthesis (MED-EL, Innsbruck, Austria). The clinical data was retrospectively analyzed. Follow-up examination included access to medical records (for adverse events) of the patients, ear microscopy and pure-tone audiometry to determine the post-operative pure tone average of the frequencies 0.5, 1, 2 and 3&#xa0;kHz (PTA<sub>4</sub>). The post-operative PTA<sub>4</sub> air bone gap (ABG) was used to evaluate the audiological outcome. A post-operative PTA<sub>4</sub> ABG ≤ 20&#xa0;dB was defined as successful rehabilitation. A post-operative minimum and maximum follow-up period was not defined.</p> Results <p>189 patients were implanted with a MED-EL stapes prosthesis mainly as treatment of hearing loss caused by otosclerosis. 188 (186 adults, 2 children; 57 conductive hearing loss (CHL), 131 mixed hearing loss (MHL)) patients were examined for adverse events (AEs). 168 (166 adults, 2 children, 51 CHL, 117 MHL) patients underwent audiological examination. Audiology: 110 (65.5%) patients achieved a post-operative PTA<sub>4</sub> ABG ≤ 10&#xa0;dB. 154 (91.7%) patients achieved a post-operative PTA<sub>4</sub> ABG ≤ 20&#xa0;dB and therefore successful rehabilitation. Individual bone conduction (BC) PTA<sub>4</sub> thresholds were stable in 159 (94.6%) patients. AEs: 12 (6.4%, adults only) patients had 13 AEs.</p> Conclusion <p>Clinical data demonstrated satisfactory audiological results after implantation of the mAXIS Stapes Prosthesis, mLOOP Stapes Prosthesis, mZAM Stapes Prosthesis, and mFIX Stapes Prosthesis. The MED-EL stapes prostheses are safe and effective.</p> Trial registration number <p>NCT05565339 (clinicaltrials.gov).</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinical outcomes of 188 patients implanted with Med-El stapes prostheses

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月15日

查看全文
  • Wendelin Wolfram,
  • Paul Martin Zwittag,
  • Lisa Niederwanger,
  • Nina Rubicz,
  • Georg Sprinzl,
  • Astrid Magele,
  • Dirk Beutner,
  • Nicholas Bevis,
  • Esther Schimanski,
  • Susan Arndt,
  • Christian Offergeld,
  • Christoph Arnoldner,
  • Dominik Riss,
  • Piotr H. Skarżyński,
  • Łukasz Plichta,
  • Joachim Hornung,
  • Lava Taha,
  • Thomas Lenarz,
  • Susan Busch,
  • Franz Windisch,
  • Benjamin Loader

摘要

Purpose

This multicentric, retrospective study aimed to analyze the safety and effectiveness of the mAXIS Stapes Prosthesis, mLOOP Stapes Prosthesis, mZAM Stapes Prosthesis, and mFIX Stapes Prosthesis.

Methods

Patients underwent stapes surgery and implantation of a mAXIS Stapes Prosthesis, mLOOP Stapes Prosthesis, mZAM Stapes Prosthesis, or mFIX Stapes Prosthesis (MED-EL, Innsbruck, Austria). The clinical data was retrospectively analyzed. Follow-up examination included access to medical records (for adverse events) of the patients, ear microscopy and pure-tone audiometry to determine the post-operative pure tone average of the frequencies 0.5, 1, 2 and 3 kHz (PTA4). The post-operative PTA4 air bone gap (ABG) was used to evaluate the audiological outcome. A post-operative PTA4 ABG ≤ 20 dB was defined as successful rehabilitation. A post-operative minimum and maximum follow-up period was not defined.

Results

189 patients were implanted with a MED-EL stapes prosthesis mainly as treatment of hearing loss caused by otosclerosis. 188 (186 adults, 2 children; 57 conductive hearing loss (CHL), 131 mixed hearing loss (MHL)) patients were examined for adverse events (AEs). 168 (166 adults, 2 children, 51 CHL, 117 MHL) patients underwent audiological examination. Audiology: 110 (65.5%) patients achieved a post-operative PTA4 ABG ≤ 10 dB. 154 (91.7%) patients achieved a post-operative PTA4 ABG ≤ 20 dB and therefore successful rehabilitation. Individual bone conduction (BC) PTA4 thresholds were stable in 159 (94.6%) patients. AEs: 12 (6.4%, adults only) patients had 13 AEs.

Conclusion

Clinical data demonstrated satisfactory audiological results after implantation of the mAXIS Stapes Prosthesis, mLOOP Stapes Prosthesis, mZAM Stapes Prosthesis, and mFIX Stapes Prosthesis. The MED-EL stapes prostheses are safe and effective.

Trial registration number

NCT05565339 (clinicaltrials.gov).